Regulation of health insurance systems is a complex undertaking considering the complexity of health insurance markets and the diverse stakeholder interests to be managed. The theory of “managed competition” proposes regulation of health insurance systems by a “sponsor” who manages the market of insurers and sets rules for their participation in the system. Conceptually envisioned at the level of a company’s employees, the concept has found application in national-level systems in multiple countries. One such country in Europe with a strong solidarity orientation has implemented the theory’s tenets to a large extent. We characterise the National Health Insurance system of Israel, its universal public healthcare system, as one which has adopted managed competition and achieved remarkable outcomes. We place the establishment of the system in the country’s political-economic context to determine the role of the structural factors in shaping health policy in the country. We trace the original values and structures of the healthcare system and the subsequent reforms that arose due to competing institutional and political interests. The system remains mired in the challenge of meeting its equity objective of providing effective healthcare access to all while balancing the country’s overall policy goal of efficiency.
Read the full report here.
Cite this paper:
APA
Nambiar, Anjali. 2022. “Managed Competition in the National Health Insurance System of Israel.” Dvara Research.
MLA
Nambiar, Anjali. “Managed Competition in the National Health Insurance System of Israel.” 2022. Dvara Research.
Chicago
Nambiar, Anjali. 2022. “Managed Competition in the National Health Insurance System of Israel.” Dvara Research.
